Europe Finance Weekly
SEE OTHER BRANDS

Fresh finance and banking news from Europe

Europe Finance Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.

Press releases published on April 8, 2025

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

‒ Q1 2025 Unaudited Net Revenue of $39.0 million ‒ ‒ Expected Q1 Adjusted EBITDA above $22.5 million ‒ ‒ Q1 2025 Cash and Cash Equivalents of Approximately $77.5 million ‒ BERKELEY HEIGHTS, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: …

Abaxx Provides Q1 2025 Corporate Update

Abaxx Provides Q1 2025 Corporate Update

TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity …

Tariffs, Tension, and the Talk that’s not happening: Half of Canadian parents haven’t discussed inheritance plans with their children

Tariffs, Tension, and the Talk that’s not happening: Half of Canadian parents haven’t discussed inheritance plans with their children

TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- A new national study by the Money Wise Institute exposes a growing communication gap between Canadian parents and their children regarding inheritance, wealth transfer, and financial expectations. With …

Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA

Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA

SAN DIEGO and TOKYO, April 08, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA, “Kura”), and Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”), today announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once- …

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the American Academy of …

O2Gold Announces C$1.5M Non-Brokered Private Placement Financings

O2Gold Announces C$1.5M Non-Brokered Private Placement Financings

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- O2Gold Inc. (NEX:OTGO.H) (“O2Gold” or the “Company”) is pleased to announce that it intends to complete best efforts non-brokered …

AGF Management Limited Declares First Quarter 2025 Dividend

AGF Management Limited Declares First Quarter 2025 Dividend

TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- On April 7, 2025, the Board of Directors of AGF Management Limited declared a dividend of 12.5 cents per share on both the Class B Non-Voting shares and the Class A Voting common shares of the company. This …

AGF Management Limited Reports First Quarter 2025 Financial Results

AGF Management Limited Reports First Quarter 2025 Financial Results

TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- Reported quarterly adjusted diluted earnings per share of $0.48 Total assets under management and fee-earning assets of $53.8 billion Increased quarterly dividend per share to 12.5 cents AGF Management Limited ( …

La Société de Gestion AGF Limitée annonce ses résultats financiers pour le premier trimestre de l’exercice 2025

La Société de Gestion AGF Limitée annonce ses résultats financiers pour le premier trimestre de l’exercice 2025

TORONTO, 08 avr. 2025 (GLOBE NEWSWIRE) -- Résultat dilué ajusté par action de 0,48 $ pour le trimestre Actif géré et actifs donnant droit à des commissions totalisant 53,8 milliards $ Augmentation du dividende trimestriel par action à 12,5 cents La Société …

EvolveImmune Therapeutics Announces Translational Research Collaboration to Evaluate Expression of Novel Tumor Target in Muscle-Invasive Bladder Cancer

EvolveImmune Therapeutics Announces Translational Research Collaboration to Evaluate Expression of Novel Tumor Target in Muscle-Invasive Bladder Cancer

BRANFORD, Conn. and NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immuno-oncology company developing next-generation T cell engager biotherapeutics to overcome cancer cell resistance to current immunotherapies, today announced …

Real World Assets (RWA Inc.) Appoints Stephen Schueler to Board of Directors

Real World Assets (RWA Inc.) Appoints Stephen Schueler to Board of Directors

COPENHAGEN, Denmark, April 08, 2025 (GLOBE NEWSWIRE) -- Real World Assets (RWA Inc.), a leader in the tokenization of real-world assets, is excited to announce the appointment of Stephen Schueler to its Board of Directors, effective immediately. Schueler …

La Société de Gestion AGF Limitée déclare un dividende pour le premier trimestre de 2025

La Société de Gestion AGF Limitée déclare un dividende pour le premier trimestre de 2025

TORONTO, 08 avr. 2025 (GLOBE NEWSWIRE) -- Le 7 avril 2025, le conseil d’administration de La Société de Gestion AGF Limitée a déclaré un dividende de 12,5 cents par action pour les actions de catégorie B sans droit de vote et pour les actions ordinaires de …

ECARX Announces Upsizing and Extension of Share Repurchase Program

ECARX Announces Upsizing and Extension of Share Repurchase Program

SHANGHAI, April 08, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings, Inc. (Nasdaq: ECX) (“ECARX” or “the Company”), a global mobility tech provider, today announced that the Company’s board of directors has approved an additional US$20 million in share repurchase …

Questor Announces Award of $2.4MM Contract

Questor Announces Award of $2.4MM Contract

CALGARY, Alberta, April 08, 2025 (GLOBE NEWSWIRE) -- Questor Technology Inc. (“Questor”, the “Company”), listed on the TSX Venture Exchange under the ticker QST, has secured a $2.4 million contract to supply clean combustion solutions in Iraq. This Middle …

OTC Markets Group Welcomes TDG Gold Corp. to OTCQX

OTC Markets Group Welcomes TDG Gold Corp. to OTCQX

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced TDG Gold Corp. (TSXV: TDG; OTCQX: TDGGF), a major mineral tenure holder …

Microbix Provides Business Updates

Microbix Provides Business Updates

MISSISSAUGA, Ontario, April 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the Company”), a life sciences innovator, manufacturer, and exporter, provides an update on U.S. and reciprocal tariff outcomes as …

Tariffs Set to Drive Up Electronics Prices—New Survey Shows 53% of Shoppers Are Holding Out for Sales

Tariffs Set to Drive Up Electronics Prices—New Survey Shows 53% of Shoppers Are Holding Out for Sales

BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- As new U.S. tariffs take effect, the cost of laptops, smartphones, and other electronics could increase by up to 11%, according to a Joint Economic Committee analysis. With prices climbing, consumers are adapting— …

Aya Gold & Silver Reports High-Grade Drill Results at Boumadine, Extends Tizi Zone to 2.2km and Identifies New Regional Targets

Aya Gold & Silver Reports High-Grade Drill Results at Boumadine, Extends Tizi Zone to 2.2km and Identifies New Regional Targets

MONTREAL, April 08, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce new high-grade drill exploration results from its 2024 - 2025 program at Boumadine in the Kingdom of Morocco. …

Theratechnologies Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLA

Theratechnologies Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLA

FDA action allows for unrestricted distribution of EGRIFTA SV®, removing uncertainty with respect to all manufactured batches PAS approval follows recent FDA approval of new formulation, EGRIFTA WR™ MONTREAL, April 08, 2025 (GLOBE NEWSWIRE) -- …

Forsys Reports Positive Ore Sorting Testwork at Norasa

Forsys Reports Positive Ore Sorting Testwork at Norasa

TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- Forsys Metals Corp. (TSX: FSY) (FSE: F2T) (NSX: FSY) (“Forsys” or the “Company”) Forsys is pleased to report on ore-sorting testwork at its Norasa Uranium project (“Norasa”1). Highlights Exploratory ore sorting …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service